TMPRSS2-ERG fusion prostate cancer is a molecularly distinct estrogen-sensitive subclass of aggressive prostate cancer
K. D. Mertz, S. R. Setlur,Y. Hoshida,F. Demichelis, M. Lupien,S. Perner,A. Sboner, Y. Pawidan,O. Andren,L. A. Johnson, J. Tang,H. O. Adami,S. Calza,A. M. Chinnaiyan,D. Rhodes,S. Tomlins,K. Fall, L. A. Mucci,P. W. Kantoff, M. J. Stampfer, S. O. Anderson, E. Varenhorst,J. E. Johansson,M. Brown,T. R. Golub, M. A. Rubin LABORATORY INVESTIGATION（2008）
AI 理解论文
溯源树
样例
